Top 5 Life Sciences Stocks To Own Right Now

Dialysis specialist DaVita HealthCare Partners (NYSE: DVA  ) has a new bean counter.

The Denver-based renal health care specialist announced today that Garry E. Menzel, Ph.D., will join the company in mid-Sptember�as senior VP of finance,�and will take on the role of chief financial officer�the day after the company files its third-quarter report with the SEC. The quarter ends Sept. 30. Jim Hilger, who has served as DaVita's interim CFO since 2012, will continue in his role as the company's chief accounting officer, a position he has held since 2010.

Menzel, 48, was most recently the COO and CFO at biopharmaceutical�Regulus Therapeutics, where he served since 2008. Before that, he had a 14-year career on Wall Street where he was a managing director and global head of life sciences for Credit Suisse and of biotechnology for Goldman Sachs. Menzel also spent several years as a strategy consultant for Bain & Company.

Belieiving they've found an executive with a versatile skill set,�DaVita HealthCare Partners Co-Chairman and CEO�Kent Thiry said, "Given the nimbleness that is required for all health care providers we are excited to have Garry join our leadership team."

Hot Restaurant Stocks To Invest In Right Now: Coronado Biosciences Inc (CNDO)

Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.

TSO

TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.

CNDO-109

CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.

The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company Coronado Biosciences (NASDAQ: CNDO  ) has received a distressing two-star ranking.

• [By Ben Fox Rubin]

  Biopharmaceutical firm Coronado Biosciences Inc.(CNDO) said a recent pilot study found that the first five patients using its potential autism treatment showed statistically significant separation from placebo, in favor of the drug. The treatment was also well-tolerated. The study is still ongoing. Shares jumped 26% to $2.25 premarket.

• [By James E. Brumley]

  The last few weeks haven't been particularly encouraging for Crohn's disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn's drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn't dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn't look good. Then this month - just a few days ago - Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn's disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn't completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn's sufferers don't need to give up home just yet, however - TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn's treatment that works, and should be able to sidestep the problems that plagued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.

• [By Roberto Pedone]

  One under-$10 biopharmaceutical player that's quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.

  If you take a look at the chart for Coronado Biosciences, you'll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.

  Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.

  Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Life Sciences Stocks To Own Right Now: Resolute Energy Corporation(REN)

Resolute Energy Corporation, an independent oil and gas company, engages in the acquisition, exploration, exploitation, and development of oil and gas properties in the United States. It primarily holds interests in the Aneth Field properties that cover approximately 43,000 gross acres on the Navajo Reservation in southeast Utah. The company? producing properties are located in the Powder River Basin, Wyoming; the Bakken shale trend of the Williston Basin in North Dakota; and the Permian Basin of Texas It also owns exploration properties in the Permian Basin of Texas; and the Big Horn and Powder River Basins of Wyoming. As of December 31, 2011, the company had estimated net proved reserves of approximately 64.8 million equivalent barrels of oil. Resolute Energy Corporation is based in Denver, Colorado.

Advisors' Opinion:

• [By Lisa Levin]

  Resolute Energy (NYSE: REN) shares fell 1.63% to reach a new 52-week low of $7.25. Resolute Energy shares have dropped 33.84% over the past 52 weeks, while the S&P 500 index has gained 20.12% in the same period.

• [By Garrett Cook]

  In trading on Wednesday, energy shares were relative leaders, up on the day by about 0.59 percent. Top gainers in the sector included Parker Drilling Co (NYSE: PKD), Alpha Natural Resources (NYSE: ANR), and Resolute Energy (NYSE: REN).

Top 5 Life Sciences Stocks To Own Right Now: Integrated Electrical Services Inc.(IESC)

Integrated Electrical Services, Inc. provides electrical infrastructure services in the United States. The company?s Communications segment offers various services, including the design, installation, and maintenance of network infrastructure for the financial, medical, hospitality, government, manufacturing, educational, and information technology industries; design and installation of audio/visual, telephone, fire, wireless, and intrusion alarm systems, as well as design/build, servicing, and maintenance of data network systems. Its Residential segment offers electrical installation services for single-family housing and multi-family apartment complexes, and CATV cabling installations for residential and commercial applications. This segment also installs residential solar power, smart meters, electric car charging stations, and stand-by generators. The company?s Commercial and Industrial segment provides electrical contracting services, which include the design of ele ctrical systems in a building or complex; procurement and installation of wiring and connection to power sources; end-use equipment and fixtures; and contract maintenance services. It also provides service, maintenance, and renovation and upgrade work services; and services for various projects, including high-rise residential and office buildings, power plants, manufacturing facilities, data centers, chemical plants, refineries, wind farms, solar facilities, municipal infrastructure, and health care facilities, as well as residential developments. In addition, this segment offers utility services consisting of overhead and underground installation and maintenance of electrical and other utilities transmission and distribution networks; installation and splicing of high-voltage transmission and distribution lines; substation construction; and substation and right-of-way maintenance. Integrated Electrical Services, Inc. was founded in 1997 and is based in Houston, Texas.

Advisors' Opinion:

• [By GuruFocus]

  Integrated Electrical Services Inc. (IESC): President and CEO James M. Lindstrom Bought 1,901 Shares
  
  President and CEO of Integrated Electrical Services Inc. (IESC) James M. Lindstrom bought 1,901 shares on 09/25/2013 at an average price of $4.08. Integrated Electrical Services Inc. has a market cap of $73.0559 million; its shares were traded at around $4.08 with and P/S ratio of 0.13.

Top 5 Life Sciences Stocks To Own Right Now: International Business Machines Corporation(IBM)

International Business Machines Corporation (IBM) provides information technology (IT) products and services worldwide. Its Global Technology Services segment provides IT infrastructure and business process services, including strategic outsourcing, process, integrated technology, and maintenance services, as well as technology-based support services. The company?s Global Business Services segment offers consulting and systems integration, and application management services. Its Software segment offers middleware and operating systems software, such as WebSphere software to integrate and manage business processes; information management software for database and enterprise content management, information integration, data warehousing, business analytics and intelligence, performance management, and predictive analytics; Tivoli software for identity management, data security, storage management, and datacenter automation; Lotus software for collaboration, messaging, and so cial networking; rational software to support software development for IT and embedded systems; business intelligence software, which provides querying and forecasting tools; SPSS predictive analytics software to predict outcomes and act on that insight; and operating systems software. Its Systems and Technology segment provides computing and storage solutions, including servers, disk and tape storage systems and software, point-of-sale retail systems, and microelectronics. The company?s Global Financing segment provides lease and loan financing to end users and internal clients; commercial financing to dealers and remarketers of IT products; and remanufacturing and remarketing services. It serves financial services, public, industrial, distribution, communications, and general business sectors. The company was formerly known as Computing-Tabulating-Recording Co. and changed its name to International Business Machines Corporation in 1924. IBM was founded in 1910 and is based in Armonk, New York.

Advisors' Opinion:

• [By Wallace Witkowski]

  Other notable earnings fall toward the tech end of the spectrum with reports from Yahoo Inc. (YHOO) , Intel Corp. (INTC) , International Business Machines Corp. (IBM) , eBay Inc. (EBAY) and Google Inc. (GOOG) .

• [By Dividends4Life]

  Related Articles
  - Genuine Parts Company (GPC) Dividend Stock Analysis
  - International Business Machines Corp. (IBM) Dividend Stock Analysis
  - Monsanto Co. (MON) Dividend Stock Analysis
  - Illinois Tool Works Inc. (ITW) Dividend Stock Analysis
  - More Stock Analysis

• [By Alex Planes]

  Boeing (NYSE: BA  ) was the single largest beneficiary of this massive outlay, as it either built or bought the companies that built all three of the Saturn V rocket booster stages, as well as its engines. IBM (NYSE: IBM  ) provided the Saturn V's instrumentation, and at a total project cost of $9.3 billion, the rocket booster accounted for nearly half of Apollo's total cost, and became a revenue windfall for these and other major NASA contractors. Apollo also nearly undid North American Aviation, which was responsible for building the Apollo I command module that caught fire and killed its three-man crew in 1967. Three months after this incident, North American merged with Rockwell-Standard, which became Rockwell International -- which is now part of Boeing.

• [By Anders Bylund]

  Here's something you don't see often. Shares of IBM (NYSE: IBM  ) have fallen as much as 7.7% today on an earnings miss -- an event as rare as chicken lips. The stock's plunge took more than 100 points off the Dow Jones Industrial Average (DJINDICES: ^DJI  ) index, dragging the blue-chip index into the red today despite the gains being made by 25 of its 30 components. The Dow's price-weighted nature magnifies IBM's every move, and today it's working against the index.